| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.94B | 11.84B | 10.91B | 9.55B | 7.77B | 6.38B |
| Gross Profit | 6.74B | 7.04B | 6.56B | 5.86B | 4.63B | 3.93B |
| EBITDA | 5.50B | 5.90B | 5.54B | 4.40B | 3.58B | 2.93B |
| Net Income | 2.84B | 2.89B | 2.86B | 1.91B | 1.69B | 1.28B |
Balance Sheet | ||||||
| Total Assets | 33.00B | 39.41B | 28.49B | 27.06B | 21.67B | 20.04B |
| Cash, Cash Equivalents and Short-Term Investments | 6.61B | 6.50B | 8.12B | 8.79B | 6.54B | 5.89B |
| Total Debt | 9.10B | 13.09B | 9.32B | 10.46B | 8.03B | 7.70B |
| Total Liabilities | 17.23B | 21.39B | 13.04B | 14.27B | 10.69B | 10.50B |
| Stockholders Equity | 15.77B | 18.02B | 15.45B | 12.79B | 10.98B | 9.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.58B | 782.75M | 776.70M | 851.89M | -1.12B |
| Operating Cash Flow | 0.00 | 3.26B | 4.17B | 2.65B | 2.85B | 1.81B |
| Investing Cash Flow | 0.00 | -8.04B | -3.47B | -2.85B | -2.24B | -3.91B |
| Financing Cash Flow | 0.00 | 3.33B | -1.38B | 2.26B | 39.93M | 3.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥201.22B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥25.83B | 8.53 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥59.00B | 18.37 | ― | 0.73% | 8.61% | 0.83% | |
72 Outperform | ¥421.05B | 24.29 | ― | 1.30% | 9.57% | 9.73% | |
67 Neutral | ¥7.36B | 57.57 | ― | 1.36% | -4.59% | -14.60% | |
67 Neutral | ¥74.23B | 7.12 | ― | 2.77% | 0.41% | 25.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |